Menu

• Ask a Health Expert about BURKITT'S LYMPHOMA
• Post Your Side Effect related to BURKITT'S LYMPHOMA
• BURKITT'S LYMPHOMA and FDA Warnings
• BURKITT'S LYMPHOMA in Patients Wiki
• Report BURKITT'S LYMPHOMA in Drug Side Effect Survey

BURKITT'S LYMPHOMA side effect

What is BURKITT'S LYMPHOMA ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Lopinavir Side Effects Report #5680366-5
Consumer or non-health professional from POLAND reported LOPINAVIR AND RITONAVIR problem on Mar 19, 2008. Male patient, 47 years of age, was diagnosed with hiv infection and was treated with LOPINAVIR AND RITONAVIR. After drug was administered, patient experienced the following problems/side effects: burkitt's lymphoma, immune reconstitution syndrome, mycobacterial infection, pneumocystis jiroveci infection, . LOPINAVIR AND RITONAVIR dosage: unknown. During the same period patient was treated with STAVUDINE, LAMIVUDINE. Patient was hospitalized. Patient died on 05/01/2003.

Maraviroc Side Effects Report #5633342-2
MARAVIROC problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 11, 2008. Male patient, weighting 143.1 lb, was diagnosed with hiv test positive and was treated with MARAVIROC. After drug was administered, patient experienced the following problems/side effects: burkitt's lymphoma, . MARAVIROC dosage: unknown. During the same period patient was treated with TRUVADA, KALETRA. Patient was hospitalized. Patient recovered.

Lopinavir Side Effects Report #5643692-1
Consumer or non-health professional from POLAND reported LOPINAVIR AND RITONAVIR problem on Feb 25, 2008. Male patient, 47 years of age, was diagnosed with hiv infection and was treated with LOPINAVIR AND RITONAVIR. After drug was administered, patient experienced the following problems/side effects: burkitt's lymphoma, immune reconstitution syndrome, mycobacterial infection, pneumocystis jiroveci infection, . LOPINAVIR AND RITONAVIR dosage: unknown. During the same period patient was treated with STAVUDINE, LAMIVUDINE. Patient was hospitalized. Patient died on 05/01/2003.

Raptiva Side Effects Report #5600308-8
RAPTIVA problem was reported by a Physician from UNITED STATES on Feb 20, 2007. Male patient, 37 years of age, weighting 209.9 lb, was diagnosed with psoriasis and was treated with RAPTIVA. After drug was administered, patient experienced the following problems/side effects: burkitt's lymphoma, . RAPTIVA dosage: 95.5 MG, 1/WEEK, SUBCUTANEOUS. Patient recovered.


Stavudine Side Effects Report #5518004-4
Health Professional from POLAND reported STAVUDINE problem on Nov 14, 2007. Male patient, 47 years of age, was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: burkitt's lymphoma, mycobacterial infection, pneumocystis jiroveci pneumonia, . STAVUDINE dosage: unknown. Patient died on 05/01/2004.

Ambisome Side Effects Report #5526167-X
AMBISOME problem was reported by a Health Professional from JAPAN on Nov 05, 2007. Male patient, 52 years of age, was diagnosed with febrile neutropenia and was treated with AMBISOME. After drug was administered, patient experienced the following problems/side effects: burkitt's lymphoma, corynebacterium sepsis, diplopia, hypokalaemia, metastases to abdominal cavity, metastases to bone marrow, metastases to central nervous system, metastases to lymph nodes, . AMBISOME dosage: 250 MG, UID/QD, IV DRIP; 150 MG, UID/QD, IV DRIP. During the same period patient was treated with VANCOMYCIN HYDROCHLORIDE, AMIKACIN SULPHATE, KALETRA, ZERIT, EPIVIR, ITRACONAZOLE, ZYLORIC. Patient died on 07/31/2007.

Prograf Side Effects Report #5487325-6
Health Professional from NEW ZEALAND reported PROGRAF problem on Sept 28, 2007. Female patient, child 3 years of age, was diagnosed with liver transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: burkitt's lymphoma, lymphoproliferative disorder, . PROGRAF dosage: 1.25 MG, BID, ORAL. Patient died on 09/28/2007.

Raptiva Side Effects Report #5380615-7
RAPTIVA problem was reported by a Physician from UNITED STATES on June 26, 2007. Female patient, 21 years of age, weighting 126.0 lb, was diagnosed with psoriasis and was treated with RAPTIVA. After drug was administered, patient experienced the following problems/side effects: burkitt's lymphoma, leukaemia, . RAPTIVA dosage: 0.6 ML, 1/WEEK. Patient was hospitalized. Patient recovered.

Raptiva Side Effects Report #5380615-7
Physician from UNITED STATES reported RAPTIVA problem on June 26, 2007. Female patient, 21 years of age, weighting 126.0 lb, was diagnosed with psoriasis and was treated with RAPTIVA. After drug was administered, patient experienced the following problems/side effects: burkitt's lymphoma, leukaemia, . RAPTIVA dosage: 0.6 ML, 1/WEEK. Patient was hospitalized. Patient recovered.


Darunavir Side Effects Report #5744203-2
DARUNAVIR problem was reported by a Pharmacist from UNITED STATES on May 15, 2008. Male patient, 57 years of age, weighting 147.7 lb, was diagnosed with hiv infection and was treated with DARUNAVIR. After drug was administered, patient experienced the following problems/side effects: burkitt's lymphoma, central nervous system lesion, neuropathy peripheral, . DARUNAVIR dosage: 600MG Q12H PO. During the same period patient was treated with RALTEGRAVIR, TRIMETHOPRIM, TENOFOVIR, RITONOVIR. Patient was hospitalized. Patient recovered.

Raptiva Side Effects Report #5370278-9
Physician from UNITED STATES reported RAPTIVA problem on June 19, 2007. Female patient, 21 years of age, weighting 126.0 lb, was diagnosed with psoriasis and was treated with RAPTIVA. After drug was administered, patient experienced the following problems/side effects: burkitt's lymphoma, leukaemia, . RAPTIVA dosage: 0.6 ML, 1/WEEK. Patient was hospitalized. Patient recovered.

Raptiva Side Effects Report #5336774-5
RAPTIVA problem was reported by a Consumer or non-health professional from UNITED STATES on May 17, 2007. Female patient, 21 years of age, weighting 126.0 lb, was diagnosed with psoriasis and was treated with RAPTIVA. After drug was administered, patient experienced the following problems/side effects: burkitt's lymphoma, leukaemia, . RAPTIVA dosage: 0.6 ML, 1/WEEK. Patient was hospitalized. Patient recovered.

Ketoderm Side Effects Report #5301707-4
Physician from reported KETODERM problem on Apr 06, 2007. Male patient, 49 years of age, weighting 165.3 lb, was diagnosed with seborrhoeic dermatitis, gastrointestinal disorder, prophylaxis, hyperuricaemia and was treated with KETODERM. After drug was administered, patient experienced the following problems/side effects: burkitt's lymphoma, cytomegalovirus test positive, lymphocytosis, neutropenia, oesophagitis ulcerative, renal failure acute, tendonitis, . KETODERM dosage: unknown. During the same period patient was treated with DEBRIDAT, BACTRIM, FASTURTEC, ARACYTIN, METHOTREXATE. Patient was hospitalized. Patient recovered.

Tracleer Side Effects Report #5688202-8
TRACLEER problem was reported by a Physician from BELGIUM on Mar 12, 2008. Male patient, 17 years of age, weighting 153.2 lb, was diagnosed with pulmonary hypertension and was treated with TRACLEER. After drug was administered, patient experienced the following problems/side effects: abdominal pain, appendicectomy, burkitt's lymphoma, chest pain, enterectomy, oxygen saturation decreased, . TRACLEER dosage: 62.5 MG, BID, ORAL. During the same period patient was treated with ROFERON, ZANTAC. Patient was hospitalized. Patient died on 03/12/2008.


Tracleer Side Effects Report #5733208-3
Physician from BELGIUM reported TRACLEER problem on Apr 23, 2008. Male patient, 17 years of age, weighting 153.2 lb, was diagnosed with pulmonary hypertension and was treated with TRACLEER. After drug was administered, patient experienced the following problems/side effects: abdominal pain, appendicectomy, burkitt's lymphoma, chest pain, enterectomy, lung disorder, oxygen saturation decreased, tumour lysis syndrome, . TRACLEER dosage: 62.5 MG, BID, ORAL. During the same period patient was treated with ROFERON, ZANTAC. Patient was hospitalized. Patient died on 03/12/2008.